Stengone Carmine N.
SEC CIK 1861519 · EDGAR
BoughtSold
Most active insiders at CTNM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lorrain Daniel S. | CSO | — | $1.13M |
| 2 | Stengone Carmine N. | CEO, Pres, Dir | — | $401.4K |
| 3 | Watkins Tim | CMO, Head of Development | — | $322.6K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-08 18:08 | 2026-09-08 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $1.01 | +2,500 | 19.7K | +15% | +$2,525 |
| DT | 2026-09-08 18:08 | 2026-09-08 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | S - Sale+OE | $16.46 | -2,500 | 17.2K | -13% | -$41.1K |
| DT | 2026-08-03 18:14 | 2026-08-03 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $1.01 | +2,500 | 19.7K | +15% | +$2,525 |
| DT | 2026-08-03 18:14 | 2026-08-03 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | S - Sale+OE | $16.01 | -2,500 | 17.2K | -13% | -$40.0K |
| DT | 2026-07-08 18:49 | 2026-07-08 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $1.01 | +2,500 | 19.7K | +15% | +$2,525 |
| DT | 2026-07-08 18:49 | 2026-07-08 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | S - Sale+OE | $16.00 | -2,500 | 17.2K | -13% | -$40.0K |
| DMT | 2026-07-01 19:04 | 2026-06-30 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $1.07 | +10.0K | 27.2K | +58% | +$10.7K |
| DT | 2026-07-01 19:04 | 2026-06-30 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | S - Sale+OE | $16.01 | -10.0K | 17.2K | -37% | -$160.1K |
| DM | 2026-02-26 | 2026-02-24+ | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $1.26 | +7,100 | 17.7K | +67% | +$8,946 |
| DM | 2026-02-26 | 2026-02-24+ | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | S - Sale+OE | $16.02 | -7,100 | 15.0K | -32% | -$113.7K |
| D | 2026-02-13 | 2026-02-11 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $1.26 | +400 | 15.4K | +3% | +$504 |
| D | 2026-02-13 | 2026-02-11 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO, Pres, Dir | S - Sale+OE | $16.00 | -400 | 15.0K | -3% | -$6,400 |
| 2024-09-12 | 2024-09-11 | KPRX | KIORA PHARMACEUTICALS INC | Stengone Carmine N. | Dir | P - Purchase | $3.68 | +1,250 | 1,250 | New | +$4,600 |
Purchase Sale Sale after option exercise All abbreviations